UnknownPhase 4NCT04797338

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Studying Ovarian hyperstimulation syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Assaf-Harofeh Medical Center
Principal Investigator: Michal Youngster, MD
Assaf-Harofeh Medical Center
Intervention: Synarel, 0.2 Mg/Inh Nasal Spray(drug)
Enrollment: 100 target
Eligibility: 18-45 years · FEMALE
Timeline: 2017 – 2021

Study locations (1)

Shamir Medical center, Be’er Ya‘aqov, Israel

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04797338 on ClinicalTrials.gov

Other trials for Ovarian hyperstimulation syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07043322
Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome
Tanta University

See all trials for Ovarian hyperstimulation syndrome →

← Back to all trials